Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Tong Ren Tang's Dingzhi Wan Receives Hong Kong Proprietary Chinese Medicine Registration – HKCMP Certificate Expands Neurological Wellness Product Line
CompanyDrug

Tong Ren Tang’s Dingzhi Wan Receives Hong Kong Proprietary Chinese Medicine Registration – HKCMP Certificate Expands Neurological Wellness Product Line

Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG: 3613) announced that it has received the Certificate of Registration of Proprietary Chinese Medicine from the Chinese Medicine Council of Hong…

Sino Biopharmaceutical Completes Phase III Enrollment for TQC3721 Inhaled PDE3/4 Inhibitor in COPD – Dual‑Target Therapy Eyes First‑in‑China Approval

Sino Biopharmaceutical Completes Phase III Enrollment for TQC3721 Inhaled PDE3/4 Inhibitor in COPD – Dual‑Target Therapy Eyes First‑in‑China Approval

Huadong Medicine's Oral GLP‑1 Agonist HDM1002 Delivers Positive Phase III Results for Weight Management – Pre‑NDA Complete, China Marketing Application Imminent

Huadong Medicine’s Oral GLP‑1 Agonist HDM1002 Delivers Positive Phase III Results for Weight Management – Pre‑NDA Complete, China Marketing Application Imminent

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

NK CellTech’s NK-Cell Therapy Gets Green Light from China’s NMPA for Solid Tumor Treatment

CompanyDrug

Laekna Therapeutics’ mCRPC Drug Combo Advances to Phase III with FDA Approval

CompanyDrug

Changchun High & New Technology Industries Gets Green Light for Jinnamab Clinical Trial

CompanyDrug

Sichuan Biokin’s BL-B01D1 Advances to Phase III for HR+/HER2- Breast Cancer

CompanyDrug

Alphamab Oncology’s JSKN016 Begins Phase I Clinical Trial for Solid Tumor Treatment

CompanyDrug

Jiangsu Hengrui’s SHR1905 Anti-TSLP mAb Gets Green Light for COPD Clinical Trial

CompanyDrug

ImmuneOnco Biopharmaceuticals’ CD47 Inhibitor Receives NMPA Go-Ahead for Phase III Trial

CompanyDrug

Bayer’s 225Ac-PSMA-Trillium Therapy Begins Early-Stage Clinical Trial for mCRPC

Show More